GlassScriptPhysician profile
Duan Huang
NPI 1659329431
$774.11
in general payments reported to CMS, 2019-2025
16 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.10 · 2020: $12.88 · 2023: $242 · 2024: $105 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.16 | 2023-2025 | |
| Corium, LLC | $98.40 | 2023-2025 | Azstarys |
| Alkermes, INC. | $80.10 | 2023-2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $76.87 | 2019-2025 | Spravato |
| Axsome Therapeutics, INC. | $59.88 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $53.15 | 2023-2025 | Abilify Maintena, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.56 | 2023-2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $40.56 | 2025 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $35.17 | 2023-2025 | Uzedy, Austedo Xr |
| Vanda Pharmaceuticals INC. | $24.97 | 2025 | Fanapt |
| Biogen, INC. | $22.81 | 2025 | Zurzuvae |
| Neurocrine Biosciences, INC. | $22.59 | 2025 | |
| Lundbeck LLC | $21.08 | 2023 | Rexulti |
| Vertical Pharmaceuticals, LLC | $15.70 | 2025 | Relexxii |
| Takeda Pharmaceuticals U.S.A., INC. | $15.21 | 2025 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.90 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duan Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.